Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
107,809,066
-
Number of holders
-
289
-
Total 13F shares, excl. options
-
85,253,157
-
Shares change
-
+5,077,645
-
Total reported value, excl. options
-
$2,599,308,572
-
Value change
-
+$153,798,142
-
Put/Call ratio
-
137%
-
Number of buys
-
156
-
Number of sells
-
112
-
Price
-
$30.49
Institutional Holders of Intellia Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NTLA) as of Q4 2023
As of 31 Dec 2023 Intellia Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NTLA) had 289 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 85,253,157 shares of stock of the company.
Largest 10 holders included ARK Investment Management LLC, BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, Sumitomo Mitsui Trust Holdings, Inc., Nikko Asset Management Americas, Inc., MORGAN STANLEY, WELLINGTON MANAGEMENT GROUP LLP, Deep Track Capital, LP, and FEDERATED HERMES, INC..
This table shows 289 institutional shareholders of the security as of 31 Dec 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.